Amgen Inc./OS/Put [280]/JPMD

Product class

Warrant - Classic

Last exchange day

15/01/2027

Performance (1M)

-

Basis price

280.0000 [USD]

Cap

- []

Leverage

67.36

Delta

-0.11

Agio p.a. in %

25.60 %

Implicit volatility

36.86 %

Amgen Inc. ISIN: US0311621009
322.00 / 322.40 | -0.30 (-0.093%)Bid/Ask| Change

Trade further warrants for Amgen Inc. without exchange fees.

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.45 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 04:09:56 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.450.45
PREV. DAY'S PRICE0.5 (07/21)
CHANGE DAY BEFORE
-0.05
-10.00 %
52 WEEK HIGH / LOW (-) (-)

Indicators

TIME OF CALCULATION
18:37:56 PM (07/22/2026)
AGIO P.A. IN %
25.60 %
LEVERAGE
67.36
DELTA
-0.11
IMPLICIT VOLATILITY
36.86 %
OMEGA
7.22
THETA
-0.29
VEGA
0.04

Master Data

WKN
JY0DGW
ISIN
DE000JY0DGW5
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Leverage Product
PRODUCT CLASS
Warrant - Classic
PRODUCT NAME
Optionsschein auf Amgen Inc.
ISSUER
J.P. Morgan SE
TRADING SEGMENT
EUWAX
OPTION TYPE
put
UNDERLYING
AMGEN INC COM USD0.0001
BASIS PRICE
280.0000 [USD]
CAP
- []
KNOCKIN LEVEL
- [-]
RANGE
- - -
MULTIPLIER
0.10
EXERCISE TYPE
American
TRADING CURRENCY
Euro
NOMINAL CURRENCY
EUR
SETTLEMENT CURRENCY
Euro
SMALLEST TRADABLE UNIT
1.00
MINIMUM QUOTATION EUR
3,000.00
MINIMUM QUOTATION UNITS
10,000.00
LAST VALUATION DAY
15/01/2027
PAYMENT DATE
22/01/2027
FIRST EXCHANGE DAY
25/06/2026
LAST EXCHANGE DAY
15/01/2027
TRADING HOURS
08:00:00 AM - 10:00:00 PM
QUOTATION
fortlaufende Auktion
ISSUE VOLUME
30,000,000
QUANTO
No

Underlying

WKN867900
ISIN
US0311621009
SYMBOL
AMG
NOMINAL CURRENCY
Euro
TYPE OF UNDERLYING
Equity
COUNTRY OF THE HOME STOCK EXCHANGE
Germany

Issuer

NAME
J.P. Morgan SE
ADDRESS
J.P. Morgan SE Taunustor 1 (Taunusturm) 60310 Frankfurt am Main Deutschland
EMAIL ADDRESS
kontakt.zertifikate@jpmorgan.com
SERVICE PHONE NUMBER
069 71240
URLhttps://jpmorgan-zertifikate.de
DOCUMENTSPRIIP / KID (english)PDF icon

Product Description

This (put) warrant is linked to Amgen Inc., the underlying instrument, and has a term ending on January 22, 2027. This is a leveraged product, where the investor participates disproportionately in the positive and negative performance of the underlying. The investor has the right to exercise throughout the term of the warrant. Upon exercise, the redemption amount is calculated as the difference between the strike price and the price of the underlying, adjusted for the multiplier of 0.10. Exercise occurs automatically at the end of the term. If, at that point in time, the price of the underlying is above the strike price, the product will expire worthless.